Dr. Geary is Chief Development Officer and Executive Vice President of Development at Ionis. He is responsible for preclinical development, global clinical development and regulatory, and manufacturing for Ionis’ drugs. Since joining Ionis in 1995, Dr. Geary has been involved in discovery and development including the regulatory submission of more than forty investigational new drug applications and seven successful antisense medicine late-stage development programs through approvals in multiple jurisdictions.

Dr. Geary received his Ph.D. in Biopharmaceutics from the University of Texas, College of Pharmacy, Austin, Texas and his B.S. in Biology from Texas A&M University, College Station, Texas.